Christopher Hebert, MD
Foot and Ankle Surgery · Lafayette, LANPI 1811994759
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (38.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 65.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,696 and has fallen 94.3% since, to $153 in 2025.
Across 33 payments — averaging $99.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- ALON Medical Technology$597
- Stryker$235
- Bioventus LLC$83
- Treace Medical Concepts, Inc.$79
- Stimwave Technologies Incorporated$64
- plus $85 from 3 others
What the payments were for
- Travel & lodging$1,03131%
- Food & beverage$1,00831%
- Education$1,25138%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $2,147 |
| ALON Medical Technology | 4 | $597 |
| Stryker | 7 | $235 |
| Bioventus LLC | 4 | $83 |
| Treace Medical Concepts, Inc. | 1 | $79 |
| Stimwave Technologies Incorporated | 1 | $64 |
| Globus Medical | 1 | $45 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Boston Scientific | 1 | $16 |
How this compares
$3,290 in reported general payments places this provider in the 55th percentile of 92 foot and ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 25 | $234 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $91 |
| Diclofenac Sodium | 11 | $62 |
| Meloxicam | 23 | $28 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Lafayette
- James NoriegaLafayette$11K
- Noah OliverLafayette$8K
- Paul FennLafayette$4K
- Jeffery GrizzaffiLafayette$2K
- Lauren GibsonLafayette$2K
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.